Found: 6
Select item for more details and to access through your institution.
CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 165, doi. 10.3390/vaccines11010165
- By:
- Publication type:
- Article
Antiproliferative and Immunoregulatory Effects of Azelaic Acid Against Acute Myeloid Leukemia via the Activation of Notch Signaling Pathway.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01396
- By:
- Publication type:
- Article
CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01178-z
- By:
- Publication type:
- Article
Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 212, doi. 10.1002/hon.2955
- By:
- Publication type:
- Article
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-14523-0
- By:
- Publication type:
- Article
A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 10587, doi. 10.2147/OTT.S229122
- By:
- Publication type:
- Article